LabCompass

Payal Desai

Medicine · The Ohio State University

Established · publishing since 1984

Publications

157

Citations

1,592

Est. group size

~9

Recurring co-author estimate

Active years

43

Publishing since 1984

Research summary
AI-generated

Payal Desai's research focuses on sickle cell disease, a genetic blood disorder affecting red blood cells, with emphasis on improving clinical care, treatment outcomes, and quality-of-life issues for patients. Work spans clinical trials of new drug therapies, kidney disease complications, pain management, emergency department care, and the transition of adolescent patients to adult healthcare systems. This research combines clinical trial data, multi-center patient registries, and healthcare quality improvement approaches.

Sickle cell disease treatment and managementChronic kidney disease and albuminuria in sickle cell patientsEmergency department and healthcare transition careClinical trials for sickle cell therapies (e.g., riociguat)Pain management and disease biomarkers

Publication output grew notably from 2017 to a peak around 2022-2024, then shows a slight decline into 2025-2026, though the researcher remains highly active with close to 15-19 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 14.8/year recently
2017: 8 publications172018: 9 publications182019: 6 publications192020: 15 publications202021: 17 publications212022: 19 publications19222023: 18 publications232024: 18 publications242025: 15 publications252026: 4 publications26
Recent publications
Publishes in
  • Blood×40
  • British Journal of Haematology×6
  • Journal of sickle cell disease.×6
  • UNC Libraries×6
  • Blood Advances×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile